Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 877 across all filing types
Latest filing 2016-06-20 Major Shareholding Noti…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding, specifically reporting the resulting distribution of total holdings after a 'Sell' transaction by Avanza Bank Holding AB for its pension fund. It explicitly mentions 'Reason for major shareholding notification Sell' and provides updated share quantities and percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ'. The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2016-06-20 English
The 100th Episealer surgery was carried out at Charité Universitätsmedizin in Berlin, Germany
Regulatory Filings Classification · 95% confidence The document is a short press release dated June 8, 2016, announcing a clinical milestone (the 100th Episealer surgery) and providing commentary from the CEO and a Board Member regarding growth and clinical results. It is not a formal regulatory filing like a 10-K, IR, or ER, nor is it a presentation (IP) or a transcript (CT). It is a general company announcement regarding operational progress and business outlook, which fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, as it does not fit the more specific categories like DIRS, DIV, or CAP. Given its nature as a press release detailing operational news, RNS is the most appropriate fallback.
2016-06-08 English
Den 100:e operationen med Episealerimplantat genomfördes vid Charité Universitätsmedizin i Berlin, Tyskland
Regulatory Filings Classification · 95% confidence The document is a press release dated June 8, 2016, announcing a clinical milestone: the 100th operation using the Episealer implant. It includes quotes from the CEO and Medical Advisor discussing growth, clinical results, and future expectations, referencing the first quarter report of 2016. This content is a general business update and announcement, not a formal regulatory filing like a 10-K, a detailed financial report (IR), or a specific transaction report (DIV, DIRS, POS). Since it is a general announcement that doesn't fit the specific categories like ER (Earnings Release) or CT (Call Transcript), and it is not explicitly announcing the publication of a major report (RPA), the most appropriate general category for a corporate news announcement that doesn't fit elsewhere is Regulatory Filings (RNS), which often serves as a catch-all for press releases of this nature, especially those concerning operational milestones and general business updates.
2016-06-08 Swedish
Episurf Medical AB presenterar vid Småbolagsdagen den 13 juni i Stockholm
Regulatory Filings Classification · 99% confidence The document is a short press release (1399 characters) from Episurf Medical AB announcing their participation and presentation at an investor event called 'Småbolagsdagen' (Small Cap Day) on June 13th. It provides contact information and a brief company overview. It is not a formal regulatory filing (like 10-K, IR, ER), nor is it a transcript, audit report, or specific financial announcement (like dividend or capital change). Since it announces participation in an investor-facing event, it is best classified as general Investor Information. Given the options, 'Investor Presentation' (IP) is often used for materials presented at such events, but this document is merely an *announcement* of attendance, not the presentation itself. The 'Menu vs Meal' rule suggests that announcements of events or reports should be treated differently. Since it is an announcement related to investor relations activities that doesn't fit the other specific categories (like DIRS, DIV, ER), the most appropriate general category for investor-facing announcements that aren't formal reports is often 'Regulatory Filings' (RNS) as a fallback, or potentially 'Investor Presentation' (IP) if we interpret the announcement as preparatory material for an investor presentation. However, given the nature of announcing attendance at a general investor day, and the lack of specific content from a formal presentation, RNS (Regulatory Filings) serves as the best general catch-all for non-standard, short corporate announcements that are not explicitly covered elsewhere.
2016-06-07 Swedish
Episurf Medical AB to present at Småbolagsdagen, held in Stockholm, June 13
Report Publication Announcement Classification · 99% confidence The document is a short company announcement dated June 7, 2016, stating that Episurf Medical AB will present at an investor conference ('Småbolagsdagen') on June 13. It provides details about the event, the representatives attending, and contact information. This is not a formal regulatory filing like a 10-K, IR, or ER. It is an announcement about an upcoming investor event, which falls under general investor relations communication. Since there is no specific category for 'Investor Event Announcement,' and it is not a report itself, the most appropriate general category is 'Regulatory Filings' (RNS) as a miscellaneous regulatory/investor communication, or potentially 'Investor Presentation' (IP) if the presentation material itself was attached, but here it is only an announcement *about* presenting. Given the nature of announcing participation in an external investor day, RNS is the safest fallback for a general company announcement that doesn't fit the specific financial report codes.
2016-06-07 English
Change in shares and number of votes in Episurf Medical AB
Share Issue/Capital Change Classification · 98% confidence The document is a short company announcement dated May 31, 2016, detailing a 'Change in shares and number of votes' due to the conversion of class A shares to class B shares. This directly relates to a change in the company's capital structure (share count and class distribution). This aligns best with the 'Share Issue/Capital Change' definition (SHA), which covers changes in capital structure, including share class adjustments. It is not an earnings release, a proxy statement, or a formal annual report. Given its specific nature regarding share counts, SHA is the most precise fit over the general RNS.
2016-05-31 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.